Why participating in clinical trials would be a positive experience: 

The CONNEX program includes three separate studies 

Depending on which study they join, participants in CONNEX will be in a study for approximately 8 months (35 weeks). Participants will also be asked to attend up to 15 study clinic visits.

CONNEX will compare the effects of an investigational drug with an inactive drug (a placebo).

Placebo is a tablet that looks like an investigational drug but contains no active ingredients. Participants in CONNEX will be randomly assigned to receive either the investigational drug or placebo.

Requirements you must meet:

Download the CONNEX material and take it with you:

ADEPT-1 Study

Evaluating the safety and efficacy of KarXT, an investigational drug, for the treatment of psychosis associated with Alzheimer’s disease dementia.


Evaluating the effectiveness of the investigational medication, Luvadaxistat, in individuals with schizophrenia, to improve their cognitive function.


Asking if an investigational drug can improve cognition in people with schizophrenia